Predictions
Kura Oncology Inc
Start price
Target price
Perf. (%)
€17.70
25.01.24
25.01.24
€16.00
31.08.25
31.08.25
9.60%
02.02.24
02.02.24
Could be very worthwhile Investment >20% year
H&R GmbH & Co. KGaA
Start price
Target price
Perf. (%)
€4.80
23.01.24
23.01.24
€6.00
23.01.25
23.01.25
4.58%
03.02.24
03.02.24
Good culture
Revenue growth >5% per year expected
Capable Management
Little innovation
Wasgau Produktions & Handels AG
Start price
Target price
Perf. (%)
€10.90
23.01.24
23.01.24
-
23.01.25
23.01.25
-6.42%
03.02.24
03.02.24
Top 10 in its market
Future proof or reliable business model
Could be very worthwhile Investment >20% year
Rising EBIT margin expected
Coherus Bioscien.
Start price
Target price
Perf. (%)
€2.21
23.01.24
23.01.24
-
23.01.25
23.01.25
-15.48%
03.02.24
03.02.24
Probably not worthwhile Investment
G1 Therapeutics
Start price
Target price
Perf. (%)
€3.38
22.01.24
22.01.24
-
22.01.25
22.01.25
14.50%
03.02.24
03.02.24
Could be very worthwhile Investment >20% year
Coherus Bioscien.
Start price
Target price
Perf. (%)
€2.92
22.01.24
22.01.24
-
22.01.25
22.01.25
-36.03%
03.02.24
03.02.24
Probably not worthwhile Investment
Actinium Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€4.54
21.01.24
21.01.24
-
21.01.25
21.01.25
6.61%
03.02.24
03.02.24
Could be worthwhile Investment >10% per year
ProQR Therapeutics N.V.
Start price
Target price
Perf. (%)
€1.67
21.01.24
21.01.24
-
21.01.25
21.01.25
18.80%
03.02.24
03.02.24
Could be worthwhile Investment >10% per year
Mersana Therapeutics
Start price
Target price
Perf. (%)
€2.44
21.01.24
21.01.24
-
21.01.25
21.01.25
23.55%
03.02.24
03.02.24
Could be worthwhile Investment >10% per year
TG Therapeutics Inc.
Start price
Target price
Perf. (%)
€13.91
21.01.24
21.01.24
-
21.01.25
21.01.25
7.87%
03.02.24
03.02.24
Could be very worthwhile Investment >20% year
Cytokinetics Inc.
Start price
Target price
Perf. (%)
€75.00
21.01.24
21.01.24
-
21.01.25
21.01.25
-2.67%
03.02.24
03.02.24
Could be worthwhile Investment >10% per year
Immunic Inc.
Start price
Target price
Perf. (%)
€1.02
20.01.24
20.01.24
€2.50
30.06.24
30.06.24
3.24%
30.06.24
30.06.24
Could be very worthwhile Investment >20% year
Mercialys Inh.
Start price
Target price
Perf. (%)
€10.56
20.01.24
20.01.24
-
20.01.25
20.01.25
-0.57%
03.02.24
03.02.24
Could be worthwhile Investment >10% per year
Carparts.com Inc.
Start price
Target price
Perf. (%)
€0.94
19.01.24
19.01.24
-
19.02.24
19.02.24
-
22.01.24
22.01.24
Probably not worthwhile Investment
ProQR Therapeutics N.V.
Start price
Target price
Perf. (%)
€1.95
18.01.24
18.01.24
-
18.01.25
18.01.25
-14.44%
21.01.24
21.01.24
Could be worthwhile Investment >10% per year
Esperion Therapeutis.Inc.
Start price
Target price
Perf. (%)
€1.98
18.01.24
18.01.24
-
18.01.25
18.01.25
-3.63%
20.01.24
20.01.24
Could be worthwhile Investment >10% per year
Allakos Inc
Start price
Target price
Perf. (%)
€0.99
17.01.24
17.01.24
-
17.01.25
17.01.25
8.55%
21.01.24
21.01.24
Risky Investment
Polytec Holding AG
Start price
Target price
Perf. (%)
€3.79
10.01.24
10.01.24
€4.00
10.01.25
10.01.25
0.53%
12.01.24
12.01.24
Dependend from some customers or products
high free float
Below average Marketposition
Little known brand
Kap-beteiligungs-Ag
Start price
Target price
Perf. (%)
€14.20
10.01.24
10.01.24
€17.00
10.01.25
10.01.25
-2.82%
20.01.24
20.01.24
Capable Management
Undervalued
Top 10 in its market
Future proof or reliable business model
SGL Carbon SE
Start price
Target price
Perf. (%)
€6.51
10.01.24
10.01.24
€0.000
10.01.25
10.01.25
-9.38%
20.01.24
20.01.24
Higher EBIT margin than peer group
EBIT growth >5% per year expected
Very Future proof/growth oriented business model
Revenue growth >5% per year expected
H&R GmbH & Co. KGaA
Start price
Target price
Perf. (%)
€4.87
10.01.24
10.01.24
€6.00
10.01.25
10.01.25
-1.23%
20.01.24
20.01.24
Good culture
Revenue growth >5% per year expected
Capable Management
Little innovation